Crossover Trial of AD109 in Obstructive Sleep Apnea

NCT04580394 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Obstructive Sleep Apnea

Interventions

DRUG: AD109
DRUG: Atomoxetine
DRUG: R-oxybutynin
DRUG: Placebo
DIAGNOSTIC_TEST: Digit System Substitution Test

Sponsor

Apnimed